Content about INDIANAPOLIS

July 27, 2011
Lilly aims to educate consumers on how drug maker collaborates with physicians

Eli Lilly has launched its physician payment registry, a website that enables visitors to search payments to individual U.S.-based physicians and the institutions or research organizations that receive payments on behalf of a physician.

July 18, 2011
HHS announces the winners of 2011 Healthy Living Innovation Awards

The Department of Health and Human Services on Friday announced the winners of an awards program that highlights innovative health promotion projects that have demonstrated a significant impact on the health of the community within the past three years.

July 18, 2011
Minimal drug interaction found between Livalo, HIV drugs

A statin made by Eli Lilly and Kowa Pharmaceuticals America appears to work well with drugs used to treat HIV, according to a study presented at the sixth International AIDS Society conference on HIV Pathogenesis, Treatment and Prevention in Rome.

July 14, 2011
Eli Lilly & Co., Disney partner to create lifestyle media for families affected by Type 1 diabetes

Eli Lilly & Co. and Disney are collaborating to produce a dedicated lifestyle website and publications for families affected by Type 1 diabetes, the two companies said Thursday.

July 5, 2011
Fionnuala Walsh joins Lilly's executive committee

Eli Lilly's SVP global quality has joined the drug maker's executive committee, effective July 1.

June 30, 2011
David Siegel joins Marsh Supermarkets

Marsh Supermarkets has created a new executive position that will focus on merchandising support, including pricing, space management, corporate brands and business intelligence.

June 29, 2011
Lilly: Axiron improves hypogonadism symptoms among men

A topical drug made by Eli Lilly restored testosterone to normal levels in men with abnormally low testosterone, according to results of a late-stage clinical trial.

June 23, 2011
WellPoint's new program helps patients choose ER alternatives for nonemergency issues

Locating retail health clinics and urgent care centers just got easier for patients seeking nonemergency care when their regular doctors are not available, thanks to an emergency room program and education campaign that incorporates Google Maps launched by WellPoint's affiliated health plans.

June 20, 2011
Q&A: A new drug for Type 2 diabetes — Wa'el Hashad, Boehringer Ingelheim

Last month, the Food and Drug Administration approved Tradjenta (linagliptin), an oral Type 2 diabetes drug made by German drug maker Boehringer Ingelheim and Indianapolis-based Eli Lilly. The drug belongs to the class known as dipeptidyl peptidase-4 inhibitors, which also includes Merck’s Januvia (sitagliptin). With diabetes affecting some 26 million Americans and growing rapidly, Drug Store News spoke with Wa’el Hashad, BI’s VP cardiovascular and metabolic disorders marketing, about what the approval of Tradjenta means for the diabetes market.


June 15, 2011
Tradjenta now available in U.S. pharmacies

A new oral medication for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim has become available in pharmacies, the companies said Wednesday.

June 14, 2011
Lilly for Better Health provides patients with ways to improve well-being

Drug maker Eli Lilly has created a multichannel platform to inform and educate patients about healthy eating, physical activity and stress management.

June 9, 2011
Court vacates Amylin restraining order against Eli Lilly

A federal court has ruled in favor of drug maker Eli Lilly & Co. in a dispute with Amylin Pharmaceuticals over Lilly’s partnership with German drug maker Boehringer Ingelheim.

June 9, 2011
FDA approves labeling change for Eli Lilly insulin product

Patients with Type 1 diabetes using an insulin product made by Eli Lilly can store it in their pumps for longer periods of time, while children using it have additional options, thanks to a labeling change approved Wednesday by the Food and Drug Administration.

June 6, 2011
Alimta extends progression-free survival among patients in late-stage study

Cancer patients taking a drug made by Eli Lilly extended the amount of time they survived without their disease worsening, according to results of a study announced Sunday.

May 24, 2011
Lilly inks deal with Care Capital, NovaQuest Capital to establish BioCritica

Drug maker Eli Lilly is partnering with two private investor groups to form a new biotech company based in central Indiana, the company said Monday.

May 23, 2011
ReportersNotebook — Chain Pharmacy, 5/30/11

The FDA has approved a new treatment for Type 2 diabetes, the agency said. The FDA announced the approval of Tradjenta (linagliptin) made by Indianapolis-based Eli Lilly and German drug maker Boehringer Ingelheim.


May 16, 2011
Lilly launches TruAssist

Drug maker Eli Lilly has launched what it’s calling an “umbrella” for its patient assistance programs.

May 3, 2011
Report: Marsh Supermarkets names new CEO

A regional supermarket chain with stores in Indiana and Ohio has appointed a new CEO, according to a local report.

April 28, 2011
Court upholds Lilly's patent for Cymbalta

Drug maker Eli Lilly will get at least two more years of patent exclusivity on a drug used to treat depression, anxiety and pain resulting from diabetic neuropathy and fibromyalgia, thanks to a court order issued Wednesday.

April 18, 2011
Lilly receives complete response letter for liprotamase

The Food and Drug Administration declined to approve a drug made by Eli Lilly for treating a disease of the pancreas that often occurs in patients with cystic fibrosis, Lilly said.

April 13, 2011
Marsh Supermarkets CEO makes exit

Marsh Supermarkets CEO Frank Lazaran is leaving the company, according to published reports.

April 5, 2011
Simon launches installation of electric vehicle charging stations

Mall owner Simon Property Group announced Tuesday that it has completed its first installation of an electric vehicle charging station at one of its shopping centers.

April 4, 2011
Lilly launches Axiron

A topical medication for treating low testosterone in men now is available, drug maker Eli Lilly said.

March 18, 2011
Lilly issues warning over alcohol prep pads associated with Forteo

Drug maker Eli Lilly is warning patients to avoid using alcohol prep pads that come with one of its osteoporosis drugs due to the risk of bacterial infections.

February 14, 2011
Lilly appoints new oncology unit president

Following the exit of its oncology unit leader, drug maker Eli Lilly announced two executive changes.

© 2013 Drug Store News. All Rights Reserved.